:::

NHRI Says No Cooperation between NHRI and Domestic or Foreign Manufacturers in Developing Vaccine for H7N9 Bird Flu Virus at Present

  • Data Source:Ministry of Health and Welfare
  • Created:2013-04-26
  • Last Updated:2017-02-03

In recent days there have been false rumors about the manufacturing of a vaccine for H7N9 bird flu virus. The National Health Research Institutes (NHRI) would like to state that there is no cooperation between the NHRI and domestic or foreign manufacturers in developing a vaccine for H7N9 bird flu virus at present. 

To prevent the possible epidemic threats caused by birds that migrate south for the winter, the focus of various departments of the government is on advancing the development and manufacturing of a vaccine for H7N9 bird flu virus. 

To develop vaccines to be used for disease prevention is one of the important missions of the NHRI. The NHRI has comprehensive experience in the development of the H1N1 flu vaccine, the H5N1 flu vaccine and the enterovirus 71 vaccine. In order to cope with possible emergency situations arising from H7N9 epidemic, the NHRI has actively engaged in relevant preparation for these situations. After the government activates the mechanism for emergency manufacturing of a vaccine for H7N9 bird flu virus, the NHRI will follow the Department of Health’s policies on disease prevention and do its best to protect the lives and safety of the citizens.